Position in VCEL
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$27,175,766
-$2,194,708 QoQ
Shares Held
844,755
+3.6% QoQ
Ownership
1.65%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 90.77247249202432.ToString("F0")%
Shared 3.8917792732804184.ToString("F0")%
None 5.3357482346952665.ToString("F0")%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,215,874 across 223 Biotechnology names. VCEL ranks #47 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in VCEL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $27,175,766 | 844,755 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $29,370,474 | 815,620 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $25,108,494 | 797,855 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $32,922,806 | 773,744 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $34,242,277 | 767,420 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $41,209,514 | 750,492 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $29,321,202 | 693,993 | Shares | Defined | 2024-11-07 | |
| 2024-06-30 | $30,327,504 | 661,018 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $33,356,002 | 641,215 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $26,010,468 | 730,426 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $24,213,036 | 722,346 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $24,923,035 | 663,376 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $16,799,361 | 572,966 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $14,584,640 | 553,707 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $9,222,323 | 397,514 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $10,481,652 | 416,269 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $26,744,215 | 699,744 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $27,906,654 | 710,093 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $36,305,980 | 743,975 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $37,000,845 | 704,778 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $31,300,814 | 563,471 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $15,631,888 | 506,214 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $8,563,695 | 462,153 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $6,046,111 | 437,490 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $3,449,433 | 376,165 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||